Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 4,097,507 | 3,171,617 | 2,683,049 | 2,422,500 | 2,211,562 |
| Cost of Goods | 401,989 | 335,192 | 274,383 | 373,614 | 554,319 |
| Gross Profit | 3,695,518 | 2,836,425 | 2,408,666 | 2,048,886 | 1,657,243 |
| Operating Expenses | 2,482,896 | 2,056,845 | 1,969,029 | 1,813,460 | 1,614,146 |
| Operating Income | 1,213,611 | 779,772 | 440,020 | 236,040 | 43,416 |
| Other Income | -57,728 | 72,396 | 52,143 | 20,155 | 20,677 |
| Pre-tax Income | 1,155,883 | 852,168 | 492,163 | 256,195 | 64,093 |
| Income Tax | 365,776 | 272,423 | 278,431 | 95,484 | 39,007 |
| Net Income Continuous | 790,107 | 579,745 | 213,732 | 160,711 | 25,086 |
| Minority Interests | 6,940 | -58,427 | N/A | N/A | N/A |
| Net Income | $783,167 | $638,172 | $217,511 | $160,711 | $25,086 |
| EPS Basic Total Ops | 2.67 | 2.02 | 0.64 | 0.48 | 0.07 |
| EPS Basic Continuous Ops | 2.70 | 1.84 | 0.63 | 0.48 | 0.07 |
| EPS Diluted Total Ops | 2.65 | 1.99 | 0.63 | 0.47 | 0.07 |
| EPS Diluted Continuous Ops | 2.68 | 1.81 | 0.62 | 0.47 | 0.07 |
| EBITDA(a) | $1,675,670 | $1,160,065 | $815,890 | $638,248 | $482,851 |